Interchange Capital Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.08M Buy
16,195
+1,176
+8% +$253K 0.77% 25
2026
Q1
$3.15M Sell
15,019
-1,287
-8% -$285K 1% 21
2025
Q4
$3.73M Buy
16,306
+226
+1% +$51.5K 0.69% 26
2025
Q3
$3.72M Buy
16,080
+1,305
+9% +$266K 0.73% 24
2025
Q2
$2.74M Buy
14,775
+66
+0.4% +$12.3K 0.63% 29
2025
Q1
$3.08M Buy
14,709
+51
+0.3% +$9.91K 0.86% 22
2024
Q4
$2.6M Sell
14,658
-162
-1% -$29.8K 0.94% 24
2024
Q3
$2.93M Buy
14,820
+4
+0% +$747 1.03% 20
2024
Q2
$2.54M Buy
14,816
+13,390
+939% +$2.22M 0.93% 22
2024
Q1
$261K Buy
1,426
+48
+3% +$8.27K 0.18% 136
2023
Q4
$214K Sell
1,378
-487
-26% -$71K 0.16% 140
2023
Q3
$278K Buy
1,865
+137
+8% +$20.1K 0.22% 111
2023
Q2
$233K Sell
1,728
-11,499
-87% -$1.69M 0.18% 132
2023
Q1
$2.11M Buy
+13,227
New +$2.02M 1.14% 18
2021
Q4
Sell
-13,606
Closed -$1.47M 151
2021
Q3
$1.47M Sell
13,606
-67
-0.5% -$7.66K 2.45% 6
2021
Q2
$1.54M Sell
13,673
-123
-0.9% -$13.9K 2.38% 7
2021
Q1
$1.5M Sell
13,796
-5
-0% -$535 0.81% 28
2020
Q4
$1.48M Buy
+13,801
New +$1.33M 0.8% 24

Other funds holding ABBV

Interchange Capital Partners's ABBV Position: Q2 2026 in Review

Interchange Capital Partners increased its AbbVie (ABBV) stake by 7.8% in Q2 2026, buying an estimated $253K and bringing the position to 16,195 shares worth $4.08M. The position accounts for 0.77% of the portfolio, ranked #25.

Interchange Capital Partners first reported a position in ABBV in Q4 2020 and has held it in 18 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Interchange Capital Partners held 16,195 shares of AbbVie worth $4.08M as of Q2 2026.
  • Interchange Capital Partners bought 1,176 AbbVie shares in Q2 2026, an estimated $253K.
  • AbbVie made up 0.77% of Interchange Capital Partners's portfolio in Q2 2026, its #25 holding.
  • Interchange Capital Partners first reported a position in AbbVie in Q4 2020 and has held it in 18 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Interchange Capital Partners's 13F filing for Q2 2026, filed 20 Jul 2026.